Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Hematol Oncol ; 14(1): 182, 2021 10 30.
Article in English | MEDLINE | ID: mdl-34717720

ABSTRACT

Asparaginase is an important drug to treat childhood haematological malignancies. Data on the association between human leukocyte antigens (HLA) and asparaginase hypersensitivity among Chinese are lacking. We conducted a retrospective study to identify HLA alleles associated with asparaginase hypersensitivity among Chinese children with acute lymphoblastic leukaemia (ALL), mixed phenotype leukaemia and non-Hodgkin lymphoma (NHL), who received asparaginases with HLA typing performed between 2009 and 2019. 107 Chinese patients were analysed. 66.3% (71/107) developed hypersensitivity to at least one of the asparaginases. HLA-B*46:01 (OR 3.8, 95% CI 1.4-10.1, p < 0.01) and DRB1*09:01 (OR 4.3, 95% CI 1.6-11.4, p < 0.01) were significantly associated with L-asparaginase hypersensitivities, which remained significant after adjustment for age, gender and B cell ALL [HLA-B*46:01 (adjusted OR 3.5, 95% 1.3-10.5, p = 0.02) and DRB1*09:01 (OR 4.4, 95% CI 1.6-13.3, p < 0.01)].


Subject(s)
Antineoplastic Agents/adverse effects , Asparaginase/adverse effects , Drug Hypersensitivity/genetics , HLA Antigens/genetics , Alleles , Antineoplastic Agents/therapeutic use , Asian People/genetics , Asparaginase/therapeutic use , Child , Child, Preschool , China/epidemiology , Drug Hypersensitivity/etiology , Female , Genetic Predisposition to Disease , Humans , Lymphoma, Non-Hodgkin/drug therapy , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...